A randomized comparison of sirolimus- vs. paclitaxel-eluting stents for treatment of bifurcation lesions by single stent and kissing balloon: Results of the SINGLE KISS trial
“…Another study found a similar incidence of angiographic restenosis at the side branch and MACE between SES-and PES-implanted bifurcation lesions with FKI. 26 These data suggest that the side branch is prone to angiographic restenosis following main branch stenting but, even though FKI can reduce the incidence of side-branch restenosis, clear clinical benefit of FKI has not been fully elucidated.…”
Circulation Journal Official Journal of the Japanese Circulation Society http://www. j-circ.or.jp benefit of routine FKI after single stenting of bifurcation lesions. 6 In addition, inadequate side-branch dilatation may result in stent deformation or incomplete stent apposition. 7 In contrast, quantitative coronary angiography (QCA) conducted in the Nordic-Baltic Bifurcation Study III showed better expansion of the side-branch orifice in the FKI group. 6 Because delayed arterial healing characterized by exposed stent struts is considered a possible risk factor for stent thrombosis, 8 struts floating at the side-branch orifice (jailing strut) could affect thrombus formation after DES implantation. Despite these controversies, the relationship between stenting strategies and local findings, such as stent apposition, thrombus formation, and neointimal coverage, which may be associated with long-term clinical outcome, has not been well evaluated to date.Several studies have shown that the high resolution of optical coherence tomography (OCT) enables visualization of coronary arteries at the micron level for evaluation of strut coverercutaneous coronary intervention (PCI) using drugeluting stents (DES) reduces restenosis and major adverse cardiac events (MACE) compared to PCI with bare metal stents. 1 Even in the DES era, however, the procedures for bifurcation remain complex and challenging. 2,3 The single-stent strategy is currently considered preferable because the 2-stent strategy has higher rates of periprocedural myocardial infarction and long-term MACE, 4,5 which is probably associated with the increased use of contrast and prolonged procedure time. Therefore, a 1-stent strategy with a provisional approach to the side branch with final kissing inflation (FKI) might be the most acceptable strategy in clinical practice.Recently, the Nordic-Baltic Bifurcation Study III, a randomized comparison of clinical outcomes in patients with coronary bifurcation lesions treated with FKI vs. without FKI after main vessel (MV) stenting, found a similar 6-month clinical outcome between the 2 groups, raising questions regarding the Background: Treatment of coronary bifurcation lesions using a single stenting strategy is preferable over that using a 2-stent technique. The benefit of final kissing inflation (FKI), however, has not been established.
“…Another study found a similar incidence of angiographic restenosis at the side branch and MACE between SES-and PES-implanted bifurcation lesions with FKI. 26 These data suggest that the side branch is prone to angiographic restenosis following main branch stenting but, even though FKI can reduce the incidence of side-branch restenosis, clear clinical benefit of FKI has not been fully elucidated.…”
Circulation Journal Official Journal of the Japanese Circulation Society http://www. j-circ.or.jp benefit of routine FKI after single stenting of bifurcation lesions. 6 In addition, inadequate side-branch dilatation may result in stent deformation or incomplete stent apposition. 7 In contrast, quantitative coronary angiography (QCA) conducted in the Nordic-Baltic Bifurcation Study III showed better expansion of the side-branch orifice in the FKI group. 6 Because delayed arterial healing characterized by exposed stent struts is considered a possible risk factor for stent thrombosis, 8 struts floating at the side-branch orifice (jailing strut) could affect thrombus formation after DES implantation. Despite these controversies, the relationship between stenting strategies and local findings, such as stent apposition, thrombus formation, and neointimal coverage, which may be associated with long-term clinical outcome, has not been well evaluated to date.Several studies have shown that the high resolution of optical coherence tomography (OCT) enables visualization of coronary arteries at the micron level for evaluation of strut coverercutaneous coronary intervention (PCI) using drugeluting stents (DES) reduces restenosis and major adverse cardiac events (MACE) compared to PCI with bare metal stents. 1 Even in the DES era, however, the procedures for bifurcation remain complex and challenging. 2,3 The single-stent strategy is currently considered preferable because the 2-stent strategy has higher rates of periprocedural myocardial infarction and long-term MACE, 4,5 which is probably associated with the increased use of contrast and prolonged procedure time. Therefore, a 1-stent strategy with a provisional approach to the side branch with final kissing inflation (FKI) might be the most acceptable strategy in clinical practice.Recently, the Nordic-Baltic Bifurcation Study III, a randomized comparison of clinical outcomes in patients with coronary bifurcation lesions treated with FKI vs. without FKI after main vessel (MV) stenting, found a similar 6-month clinical outcome between the 2 groups, raising questions regarding the Background: Treatment of coronary bifurcation lesions using a single stenting strategy is preferable over that using a 2-stent technique. The benefit of final kissing inflation (FKI), however, has not been established.
“…Six studies involving 648 patients reported failure rates of SB crossing with a pressure guidewire [20][21][22][23][24][25] and 11 studies reported failure rates of SB crossing with a coronary guide wire in a total of 2601 patients ( Fig. 1) [10,11,[13][14][15][16][17][26][27][28][29]. Baseline characteristics with inclusion and exclusion criteria as delineated by each study are presented in Tables 1 and 2.…”
Section: Resultsmentioning
confidence: 99%
“…Most importantly, there was no difference in the prevalence of true bifurcation lesions in studies using FFR (57%) vs. studies using FKBI (62%, P = 0Á58). There were missing data for the other variables but overall, most studies included patients with relatively normal LVEF except for Nasu et al that included patients with LVEF >30% but the average LVEF in the study population was not reported (Table 2b) [16]. Prevalence of comorbidities was heterogeneous, likely due to different underlying clinical risk profiles of respective study cohorts.…”
Section: Resultsmentioning
confidence: 99%
“…All six studies that performed FFR in the SB of CBL specifically reported failure to access SB with pressure wire [20][21][22][23][24][25]. Out of the 11 studies included that performed FKBI in CBL, four studies specifically mentioned failure to pass coronary guide wire in SB after MV stenting [11,13,16,17] while three studies had a 100% success rate [14,28,29]. The remaining four studies reported overall success rates of being able to perform FKBI which indirectly provided failure rates which were then used for the analyses [10,15,26,27].…”
Section: Resultsmentioning
confidence: 99%
“…There were four studies that specifically mentioned coronary wire crossing failure in SB after MV stenting (n = 1306) [11,13,16,17]. We excluded the remaining seven studies that either reported success in all lesions [14,28,29] or in which overall success with FKBI was reported [10,15,26,27].…”
The failure rates of SB crossing after MV stenting are low with both pressure and coronary guidewire procedures, with no significant difference between the two approaches.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.